Global linear accelerator requirements and personalised country recommendations: a cross-sectional, population-based study.
Saved in:
| Title: | Global linear accelerator requirements and personalised country recommendations: a cross-sectional, population-based study. |
|---|---|
| Authors: | Moraes FY; Department of Oncology, Queen's University, Kingston, ON, Canada; Division of Cancer Care and Epidemiology, Cancer Research Institute, Queen's University, Kingston, ON, Canada. Electronic address: fydm@queensu.ca., Gouveia AG; Division of Radiation Oncology, McMaster University and Juravinski Cancer Centre, Hamilton, ON, Canada., Freitas Bratti V; Department of Public Health Sciences, Queen's University, Kingston, ON, Canada., Dee EC; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Fernandes Pavoni J; Faculty of Philosophy, Languages and Human Sciences, University of São Paulo, São Paulo, Brazil., Carson LM; Department of Oncology, Queen's University, Kingston, ON, Canada., de Sousa CFPM; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Sullivan R; Institute of Cancer Policy, Global Oncology Group, King's College London, London, UK., Nader Marta G; Department of Oncology, Division of Radiation Oncology, Hospital Sirio Libanês, São Paulo, Brazil., Hopman WM; Department of Public Health Sciences, Queen's University, Kingston, ON, Canada., Booth CM; Department of Oncology, Queen's University, Kingston, ON, Canada; Division of Cancer Care and Epidemiology, Cancer Research Institute, Queen's University, Kingston, ON, Canada., Aggarwal A; Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK; Department of Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Jemal A; Surveillance and Health Equity Science, American Cancer Society, Atlanta, GA, USA., Hanna TP; Department of Oncology, Queen's University, Kingston, ON, Canada; Division of Cancer Care and Epidemiology, Cancer Research Institute, Queen's University, Kingston, ON, Canada., Wilson BE; Department of Oncology, Queen's University, Kingston, ON, Canada; Division of Cancer Care and Epidemiology, Cancer Research Institute, Queen's University, Kingston, ON, Canada., Arruda Viani G; Ribeirão Preto Medical School, Department of Medical Imaging, Haematology and Oncology, University of São Paulo, São Paulo, Brazil. |
| Source: | The Lancet. Oncology [Lancet Oncol] 2025 Feb; Vol. 26 (2), pp. 239-248. Date of Electronic Publication: 2025 Jan 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
